Home FDA approves Novo Nordisk's weight loss injection, Saxenda
 

Keywords :   


FDA approves Novo Nordisk's weight loss injection, Saxenda

2014-12-26 06:37:52| Biotech - Topix.net

Novo Nordisk today announced that the Food and Drug Administration has approved the new drug application for Saxenda , the first once-daily glucagon-like peptide-1 receptor agonist for chronic weight management. Saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or who are overweight in the presence of at least one weight-related comorbid condition.

Tags: loss weight novo injection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
09.11Atlantic Tropical Weather Outlook
09.11Eastern North Pacific Tropical Weather Outlook
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 22
08.11Hurricane Rafael Forecast Advisory Number 22
08.11Hurricane Rafael Public Advisory Number 22
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Trump tariffs could cost UK 22bn of exports
More »